Therapy areas

First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary Endpoint in Breast...

First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary Endpoint in Breast Cancer

BioSpace Movers & Shakers, Nov. 22

BioSpace Movers & Shakers, Nov. 22

AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia

AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia

Analysis Shows Pelosi Plan Could Reduce Development of 56 New Medicines Over Next 10...

Analysis Shows Pelosi Plan Could Reduce Development of 56 New Medicines Over Next 10 Years

Alexandria Real Estate Equities is Moving Forward with San Carlos Biotech Campus

Alexandria Real Estate Equities is Moving Forward with San Carlos Biotech Campus